| Medical Board Says MDs Cheated The American Board of Internal Medicine is moving against nearly 140 doctors who it says cheated on the organization's certification exams. online.wsj.com |
Celera Corporation Q2 2010 Earnings Call Transcript Celera Corporation (CRA)Q2 2010 Earnings Call TranscriptAugust 3, 2010 4:30 pm ETComplete Story » seekingalpha.com |
PPD Appoints Neil McCullough, Ph.D., Vice President of Quality Management Systems (Business Wire) WILMINGTON, N.C.----PPD, Inc. today announced it has named Neil McCullough, Ph.D., as vice president of quality management systems. In this role, Dr. McCullough will provide strategic direction for quality management across all lines of business and ensure full compliance with global regulations guiding the biopharmaceutical industry. us.rd.yahoo.com |
BioClinica to Release Third Quarter 2010 Financial Results on November 3, 2010 [Business Wire] - BioClinica®, Inc., , a leading global provider of clinical trial management services will release its financial results for the third quarter ended September 30, 2010 on Wednesday, November 3, 2010. us.rd.yahoo.com |
Cumberland Pharma Is Flying Under the Radar Sheff Station submits:Cumberlan (CPIX) is on deck soon for the FDA to review their drug for a potential approval with their PDUFA date on 12/10/10. They filed a supplemental drug application with the FDA in the first quarter of the year to expand the label of their liver failure injectable drug Acetadote which has already hit the market to counteract overdoses of acetaminophen.Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) on the first of December announced that that an independently conducted study of Acetadote (acetylcysteine) Injection, or intravenous N-acetylcysteine, as a cost-saving treatment for acetaminophen poisoning was published in Volume 12, Number 4 of the peer-reviewed Journal of Medical Economics, distributed in December. The study concluded that Acetadote was a less costly treatment regimen than oral N-acetylcysteine in all evaluated scenarios. Complete Story » seekingalpha.com |